melanomaesophageal squamous cell carcinomaNSCLCESCCSCLCnon-small-cell lung cancerlomvastomig
… during dose-escalation (21%; n=19), and in the CPI-experienced melanoma (8%, n=38) and CPI-naïve ESCC (20%, n=15) expansion cohorts.Con…
189articles mentioning diseases
777disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: NSCLC ×
NSCLC
This disease is selected. Its supporting articles are shown below.
Articles mentioning NSCLC
189 articles · page 11 of 16non-small cell lung carcinomaNSCLCFissios Apprespiratory physiotherapyHospital Clínico San CarlosClinical Research and Clinical Trials Unit
…veloping postoperative complications in patients diagnosed with non-small cell lung carcinoma (NSCLC) scheduled for surgery. However, there is heterogeneity …
92.3%
non-small cell lung cancerNSCLCMPEWang et al
…detection rate for isolated malignant pleural effusion (MPE) in non-small cell lung cancer (NSCLC). Pleural fluid cell free DNA (cfDNA) detects all extrac…
stage II–III NSCLCNSCLCimmunotherapyCurative-intent multimodality treatmenttyrosine kinase inhibitorssystemic therapyadjuvant chemoimmunotherapyneoadjuvant and perioperative chemoimmunotherapy
…d patient-centred care is now achievable for many patients with stage II–III NSCLC—but it will require system-level adaptation to deliver it.…
NSCLCA549 non-small cell-lung cancerdoxorubicinMB-TRAIL M28z CAR-T cell therapy
…ificantly improving survival in models of MSTO-211H PM and A549 NSCLC with heterogeneous antigen expression. We also demonstrated tha…
NSCLCtriple-negative breast cancerhead and neck cancernon-small cell lung cancerCYLDRUNX1
… identify novel potential mediators, including LoF of TGFBR2 in NSCLC, CYLD in head and neck cancer, and RUNX1 in triple-negative bre…
sq-NSCLCSquamous non-small cell lung cancerNSCLCcarboplatinserplulimabpaclitaxeltaxane-carboplatinNCT05775796nab-paclitaxeltaxane
…s with an acceptable safety profile in patients with resectable sq-NSCLC. Long-term follow-up and future phase III trials are warranted …
Lung cancerNSCLC
…Introduction Lung cancer remains the leading cause of cancer mortality worldwide despite…
breast cancernon-small cell lung cancerNSCLCBCcancer treatmentsEuropean Medicines AgencyUS Food and Drug AdministrationEuroQol GroupAmerican Society of Clinical Oncology
…his study examined how PRO data from pivotal clinical trials in breast cancer (BC), gastrointestinal (GI) cancers and non-small cell lung can…
NSCLCadvanced non-small cell lung cancerICI
…expression <50%. TMB should be considered in future early-stage NSCLC ICI clinical trials to further validate these results.…
NSCLClocoregional therapy
… people living with oncogene-driven non-small cell lung cancer (NSCLC). From the patient-advocacy perspective, we wish to stimulate d…
Non-small cell lung cancerNSCLCafatinibosimertinib
…Background and Importance Non-small cell lung cancer (NSCLC) is one of the leading causes of death worldwide. In pat…